Zhihui Zhong

Zhihui Zhong


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2025 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
MCMei Chenghan
Mei Chenghan
LWLi Wanxin
Li Wanxin
ZBZhao Bangcheng
Zhao Bangcheng
HYHe Yao
He Yao
LQLi Qinxi
Li Qinxi
ZZZhihui Zhong
Zhihui Zhong

28 February 2020 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
QWQiong Wu
Qiong Wu
YZYingqian Zhang
Yingqian Zhang
YZYinbing Zhang
Yinbing Zhang
CXChunchao Xia
Chunchao Xia
QLQi Lai
Qi Lai
ZZZhihui Zhong
Zhihui Zhong

1 January 2016 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
YZYingqian Zhang
Yingqian Zhang
FFFeng Fan
Feng Fan
GZGuojun Zeng
Guojun Zeng
LZLinlin Zhou
Linlin Zhou
YZYinbing Zhang
Yinbing Zhang
ZZZhihui Zhong
Zhihui Zhong
Blood–brain barrier (BBB) disruption plays an important role in pathophysiological progress of ischemic stroke. However, our knowledge of the dynamic change of BBB permeability and its mechanism remains limited. In the current study, we used a non-human primate (NHP) MCAO model and a serial CSF sampling method that allowed us to determine the dynamic change of BBB permeability by calculating the CSF/serum albumin ratio (AR). We showed that AR increased rapidly and significantly after ischemia, and the fold increase of AR is highly correlated with the infarction size during the subacute phase. Moreover, we determined the temporal change of MMP-1, MMP-2, MMP-3, MMP-9, MMP-10, MMP-13, TIMP-1, and TIMP-2 in CSF and serum. Each MMP and TIMP showed different change patterns when comparing their values in CSF and serum. Based on the longitudinal dataset, we showed that the fold increase of MMP-9 in serum and CSF are both correlated to infarction size. Among the measured MMPs and TIMPs, only MMP-2, MMP-13, and TIMP-2 in CSF correlated with AR to some extent. Our data suggest there is no single MMP or TIMP fully responsible for BBB breakdown, which is regulated by a much more complicated signal network and further investigations of the mechanisms are needed.

2 June 2025 in Journal of Pharmaceutical Analysis
Verified
Journal Article
Open access
YHYao He
Yao He
XTXiao Tu
Xiao Tu
YXYuxin Xue
Yuxin Xue
YCYuxuan Chen
Yuxuan Chen
BYBengui Ye
Bengui Ye
QZQixing Zhong
Qixing Zhong
Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 screening technology is redefining the landscape of drug discovery and therapeutic target identification by providing a precise and scalable platform for functional genomics. The development of extensive single-guide RNA (sgRNA) libraries enables high-throughput screening (HTS) that systematically investigates gene-drug interactions across the genome. This powerful approach has found broad applications in identifying drug targets for various diseases, including cancer, infectious diseases, metabolic disorders, and neurodegenerative conditions, playing a crucial role in elucidating drug mechanisms and facilitating drug screening. Despite challenges like off-target effects, data complexity, and ethical or regulatory concerns, ongoing advancements in CRISPR technology and bioinformatics are steadily overcoming these limitations. Additionally, by integrating with organoid models, artificial intelligence (AI), and big data technologies, CRISPR screening expands the scale, intelligence, and automation of drug discovery. This integration boosts data analysis efficiency and offers robust support for uncovering new therapeutic targets and mechanisms. This review outlines the fundamental principles and applications of CRISPR screening technology, delves into specific case studies and technical challenges, and highlights its expanding role in drug discovery and target identification. It also examines the potential for clinical translation and addresses the associated ethical and regulatory considerations.

9 February 2022 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Closed access
YZYingqian Zhang
Yingqian Zhang
BZBangcheng Zhao
Bangcheng Zhao
QLQi Lai
Qi Lai
QLQinxi Li
Qinxi Li
XTXun Tang
Xun Tang
ZZZhihui Zhong
Zhihui Zhong
Blood-brain barrier (BBB) disruption is a pivotal pathophysiological process in ischemic stroke. Although temporal changes in BBB permeability during the acute phase have been widely studied, little is known about the chronic phase of cerebrovascular changes that may have a large impact on the long-term outcome. Therefore, this study was aimed to measure cerebral vascular abnormalities using CT perfusion in nine rhesus monkeys subjected to transient middle cerebral artery occlusion (tMCAO) for ≥1 year (MCAO-1Y+). The level of cerebral perfusion demonstrated by mean transit time was significantly higher in the ipsilateral caudate nucleus, white matter, thalamus, hippocampus, and contralateral thalamus in MCAO-1Y+ compared with the other nine age-matched control monkeys. The increase in BBB permeability measured through the permeability surface was found in the same ten regions of interest ipsilaterally and contralaterally. We also found decreased levels of Aβ 42/40 ratio in the cerebrospinal fluid (CSF), suggesting a potential link between post-MCAO cognitive decline and Aβ metabolism. Overall, we demonstrated significant cerebral hypoperfusion, BBB disruption, and CSF Aβ decrease during the rehabilitation stage of ischemic stroke in a non-human primate model. Future studies are needed to elucidate the cause-effect relationship between cerebrovascular disruptions and long-term neurological deficits.

12 February 2016 in The Analyst
Verified
Journal Article
Closed access
PDF file
guilong pengguilong peng
guilong peng
QHQiang He
Qiang He
HLHaifang Li
Haifang Li
DMDaniel Mmereki
Daniel Mmereki
YLYing Lu
Ying Lu
Jin-Ming LinJin-Ming Lin
Jin-Ming Lin
In this work, a new, rapid and reliable method for the determination of boron in water samples by dispersive liquid–liquid microextraction based on the solidification of a floating organic drop (DLLME-SFO) prior to fluorescence spectra analysis was developed. As a result of its complexation with boric acid, the method relies on the enhancement of the fluorescence (λex = 350 nm, λem = 373 nm) of chromotropic acid. The influences of DLLME-SFO parameters, including the extraction solvent type and its volume, pH, the disperser solvent type and its volume, and salt effects were investigated. Under the optimized conditions, the limit of detection was 0.11 ng L−1, with a preconcentration factor of 86 times. The calibration curve was linear in the range of 0–40 nM. The proposed method has also been successfully applied to analyze real water samples and the relative recoveries of water samples ranged from 86.9 to 93.2%.